NEURONETICS_logo high res.jpg
Neuronetics, Inc. Announces Appointment of Dr. Cheryl R. Blanchard to its Board of Directors
February 15, 2019 08:00 ET | Neuronetics
MALVERN, Pa., Feb. 15, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
NEURONETICS_logo high res.jpg
Neuronetics Announces Preliminary Fourth Quarter and Full Year Revenue
January 07, 2019 08:00 ET | Neuronetics
Preliminary full year 2018 total revenue of approximately $52.8 million, an increase of approximately 31% over the full year 2017, exceeding previously issued guidance MALVERN, Pa., Jan. 07, 2019 ...
NEURONETICS_logo high res.jpg
Neuronetics to Present at the 30th Annual Piper Jaffray Healthcare Conference
November 15, 2018 08:00 ET | Neuronetics
MALVERN, Pa., Nov. 15, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
NEURONETICS_logo high res.jpg
Neuronetics Reports Third Quarter 2018 Financial and Operating Results
November 06, 2018 07:00 ET | Neuronetics
MALVERN, Pa., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
NEURONETICS_logo high res.jpg
Neuronetics to Report Third Quarter 2018 Financial Results and Host Conference Call
October 23, 2018 08:00 ET | Neuronetics
MALVERN, Pa., Oct. 23, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
NEURONETICS_logo high res.jpg
Neuronetics to be Added to the Russell 2000®, 3000® and Microcap® Indexes
October 01, 2018 08:00 ET | Neuronetics
MALVERN, Pa., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial-stage medical device company focused on designing, developing, and manufacturing products that improve...
NEURONETICS_logo high res.jpg
Neuronetics Reports Second Quarter 2018 Financial and Operating Results
August 14, 2018 07:00 ET | Neuronetics
MALVERN, Pa., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
NEURONETICS_logo high res.jpg
Neuronetics, Inc. to Report Second Quarter 2018 Financial Results and Host Conference Call
July 31, 2018 06:00 ET | Neuronetics
MALVERN, Pa., July 31, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial-stage medical device company focused on designing, developing, and manufacturing products that improve...
NEURONETICS_logo high res.jpg
Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Closing of Initial Public Offering and the Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
July 02, 2018 16:48 ET | Neuronetics
MALVERN, Pa., July 02, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc., a commercial-stage medical device company focused on designing, developing, and manufacturing products that improve the quality of...
Neuronetics, Inc., Maker of NeuroStar® Advanced Therapy, Announces Pricing of Initial Public Offering
June 28, 2018 07:00 ET | Neuronetics
MALVERN, Pa., June 28, 2018 (GLOBE NEWSWIRE) -- Neuronetics, Inc., a commercial-stage medical device company focused on designing, developing, and manufacturing products that improve the quality of...